| FATE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the FATE market cap history going back to 11/11/2013:
Also see: FATE Shares Outstanding History and FATE YTD Return |
FATE Market Cap History — Fate Therapeutics Capitalization Over Time
As of 8/6/2026 Fate Therapeutics has a market cap of 298.35 million. Investors often follow the FATE market cap history to compare the size of the company over time.
This page shows FATE market capitalization trends over time, with 51 market cap datapoints presented, dating back to 11/11/2013.
| FATE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FATE Historical Market Cap: +9.43% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FATE Stock Price Chart |
| About Fate Therapeutics Inc |
| Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. Co.'s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. We show 51 historical shares outstanding datapoints in our FATE shares outstanding history coverage, used to compute FATE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing FATE market cap history over the course of time is important for investors interested in comparing FATE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of FATE versus a peer is one thing; comparing FATE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like FATE can fluctuate over the course of history. With this page we aim to empower investors researching FATE by allowing them to research the FATE market cap history. |
| FATE Current Stock Quote |
Quotes delayed 20 minutes  Free FATE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| FATE Share Performance |
| Market Cap Peers |
| Fate Therapeutics (FATE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
FBIO Market Cap History FBLG Market Cap History FBRX Market Cap History FCRE Market Cap History FCSC Market Cap History FDMT Market Cap History FEMY Market Cap History FGEN Market Cap History FHTX Market Cap History FIXX Market Cap History More Healthcare companies » |
FATE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
